Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, route de Lennik 808, Brussels 1070, Belgium.
Ann Intensive Care. 2013 Jun 27;3(1):17. doi: 10.1186/2110-5820-3-17.
Severe acute arterial hypertension can be associated with significant morbidity and mortality. After excluding a reversible etiology, choice of therapeutic intervention should be based on evaluation of a number of factors, such as age, comorbidities, and other ongoing therapies. A rational pathophysiological approach should then be applied that integrates the effects of the drug on blood volume, vascular tone, and other determinants of cardiac output. Vasodilators, calcium channel blockers, and beta-blocking agents can all decrease arterial pressure but by totally different modes of action, which may be appropriate or contraindicated in individual patients. There is no preferred agent for all situations, although some drugs may have a more attractive profile than others, with rapid onset action, short half-life, and fewer adverse reactions. In this review, we focus on the main mechanisms underlying severe hypertension in the critically ill and how using a pathophysiological approach can help the intensivist decide on treatment options.
严重的急性动脉高血压可能会导致严重的发病率和死亡率。在排除可逆转的病因后,治疗干预的选择应基于对许多因素的评估,如年龄、合并症和其他正在进行的治疗。然后应应用合理的病理生理学方法,该方法整合了药物对血容量、血管张力和心输出量其他决定因素的影响。血管扩张剂、钙通道阻滞剂和β受体阻滞剂均可降低动脉压,但作用机制完全不同,在个别患者中可能适用或禁忌。没有一种药物适用于所有情况,尽管某些药物可能具有比其他药物更有吸引力的特征,起效迅速、半衰期短、不良反应少。在这篇综述中,我们重点讨论了危重病患者严重高血压的主要机制,以及如何使用病理生理学方法帮助重症监护医生决定治疗选择。